JAVITT DANIEL C. sold 3.4% of their position (445.71K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $303.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/7/2022ACC: 0000880984-22-000007
10% Owner
Since May 2021
-445.71K
Net shares
Net seller
$303.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
445.71K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−243.60K
Price / share
$0.70
Trade value
$171.10K
% of position
1.9%
6/3/2022
13.10M→12.86M
Common Stock
Indirect
Shares
−115.66K
Price / share
$0.67
Trade value
$76.95K
% of position
0.9%
6/6/2022
12.86M→12.74M
Common Stock
Indirect
Shares
−86.46K
Price / share
$0.65
Trade value
$55.86K
% of position
0.7%
6/7/2022
12.74M→12.66M
Total
Net shares
−445.71K
Net value
-$303.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/3/2022 | S · Sale | −243.60K | $0.70 | $171.10K | 1.9% | 13.10M | 12.86M |
| Common Stock Indirect | 6/6/2022 | S · Sale | −115.66K | $0.67 | $76.95K | 0.9% | 12.86M | 12.74M |
| Common Stock Indirect | 6/7/2022 | S · Sale | −86.46K | $0.65 | $55.86K | 0.7% | 12.74M | 12.66M |
| Total | −445.71K | -$303.91K | ||||||
Derivative Transactions0
No derivative transactions reported